Medicamentsen-ligne vous propose les traitements dont vous avez besoin afin de prendre soin de votre santé sexuelle. Avec plus de 6 ans d'expérience et plus de 90.000 clients francophones, nous étions la première clinique fournissant du acheter viagra original en France à vente en ligne et le premier vendeur en ligne de Viagra dans le monde. Pourquoi prendre des risques si vous pouvez être sûr avec Medicamentsen-ligne - Le service auquel vous pouvez faire confiance.

Microsoft word - 048_ghs.doc

CHEMETALL FOOTE CORPORATION
GHS SAFETY DATA SHEET

LITHIUM HYDROXIDE MONOHYDRATE
CFM 048-GHS
Page 1 of 6
SECTION 1
CHEMICAL PRODUCT AND COMPANY IDENTIFICATION
1-800-424-9300
SUBSTANCE: LITHIUM HYDROXIDE MONOHYDRATE
TRADE NAMES/SYNONYMS: Lithium Hydroxide Hydrate; Lithium Hydroxide Hydrated;
PRODUCT USE: Used for a variety of industrial and research applications.
CHEMICAL FAMILY: Inorganic Base
FORMULA: LiOH•H2O
CREATION DATE: 4/11/96
REVISION DATE: 11/26/06(see Section 16 for revision details) SECTION 2
HAZARDS IDENTIFICATION
GHS Classification:
Health Environmental
Physical
Skin Corrosion/Irritation – Category 1B Acute Toxicity (Oral) – Category 2 (Inhalation) – Category 2 Target Organ Toxicity (repeat) – Category 1 GHS Label Prevent contact with eyes, skin and clothing. Causes severe skin burns and eye damage. Do not eat, drink or smoke while using this May cause damage to nervous system and kidneys Wash hands thoroughly after handling. Wear protective clothing, gloves and eye/face protection. Keep only in original container. SECTION 3
COMPOSITION, INFORMATION ON INGREDIENTS
Component
SECTION 4
FIRST-AID MEASURES
Victims of chemical exposure must be taken for medical attention if any adverse effect occurs. Rescuers should be taken for medical attention if necessary. Take copy of label and MSDS to physician or health professional with victim. SKIN EXPOSURE: If this solution contaminates the skin, immediately begin decontamination with running water. Do not interrupt flushing. Minimum flushing time is 15 minutes. Remove exposed or contaminated clothing, taking care not to contaminate eyes. Victims must seek immediate medical attention if adverse effect occurs. EYE EXPOSURE: If this solution contaminates the eyes, open victim's eyes while under gently running water. Use sufficient force to open eyelids. Have victim "roll" eyes. Minimum flushing is for 30 minutes. Victims must seek immediate medical attention if any adverse effect occurs. INHALATION: If Lithium Hydroxide Monohydrate is inhaled, remove victim to fresh air. If necessary, use artificial respiration to support vital functions. Remove or cover gross contamination to avoid exposure to rescuers. Seek medical attention if adverse effect occurs. INGESTION: If Lithium Hydroxide Monohydrate is swallowed, CALL PHYSICIAN OR POISON CONTROL LITHIUM HYDROXIDE MONOHYDRATE CFM 048-GHS
Page 2 of 6
SECTION 4
FIRST-AID MEASURES
CENTER FOR MOST CURRENT INFORMATION. DO NOT INDUCE VOMITING. If conscious, have victim rinse mouth with water. Never induce vomiting or give diluents (milk or water) to someone who is unconscious, having convulsions, or unable to swallow. MEDICAL CONDITIONS AGGRAVATED BY EXPOSURE: Pre-existing respiratory, skin, central nervous system, and kidney conditions can be aggravated by overexposure to Lithium Hydroxide Monohydrate. RECOMMENDATIONS TO PHYSICIANS: Treat symptoms and eliminate overexposure. SECTION 5
FIRE-FIGHTING MEASURES
FIRE EXTINGUISHING MATERIALS: Lithium Hydroxide is not flammable. Use fire extinguishing material appropriate for surrounding fires. UNUSUAL FIRE AND EXPLOSION HAZARDS: Lithium Hydroxide Monohydrate is corrosive and presents a severe contact hazard to firefighters. When involved in a fire, Lithium Hydroxide Monohydrate may decompose and produce irritating fumes and toxic gases (lithium compounds). Explosion Sensitivity to Mechanical Impact: Not sensitive. Explosion Sensitivity to Static Discharge: Not sensitive. SPECIAL FIRE-FIGHTING PROCEDURES: Incipient fire responders should wear eye protection. Structural firefighters must wear Self-Contained Breathing Apparatus and full protective equipment. Move containers from fire area if it can be done without risk to personnel. If possible, firefighters should control runoff water to prevent environmental contamination. SECTION 6
ACCIDENTAL RELEASE MEASURES
Uncontrolled releases should be responded to by trained personnel using pre-planned procedures. Proper protective equipment should be used. In case of a spill, clear the affected area and protect people. The minimum Personal Protective Equipment recommended for response to non-incidental releases should be Level C: double-gloves (nitrile gloves over latex gloves), chemical resistant suit and boots, hard-hat, and air-purifying respirator with high-efficiency particulate filter. Self-Contained Breathing Apparatus would be worn in situations where the oxygen level is below 19.5 % or is unknown. Sweep up or vacuum spilled Lithium Hydroxide Monohydrate carefully, avoiding the generation of dusts. Decontaminate the area thoroughly. If necessary, neutralize area with citric acid. Test area with litmus paper to insure neutralization is complete. Place all spill residue in a suitable container and seal. Dispose of in accordance with U.S. Federal, State, and local or Canadian solid waste disposal regulations (see Section 13, Disposal Considerations). SECTION 7
HANDLING AND STORAGE
WORK PRACTICES AND HYGIENE PRACTICES: As with all chemicals, avoid getting Lithium Hydroxide Monohydrate ON YOU or IN YOU. Wash thoroughly after handling Lithium Hydroxide Monohydrate. Do not eat, drink, or smoke while handling this product. Remove contaminated clothing immediately. Use ventilation and other engineering controls to minimize potential exposure to Lithium Hydroxide Monohydrate. STORAGE AND HANDLING PRACTICES: All employees who handle Lithium Hydroxide Monohydrate should be trained to handle it safely. Ensure containers of Lithium Hydroxide Monohydrate are properly labeled. Open containers slowly on a stable surface. Store containers in a cool, dry location, away from direct sunlight or sources of intense heat. Keep container tightly closed after use. Store away from incompatible materials (see Section 10, Stability and Reactivity). Inspect containers of Lithium Hydroxide for leaks or damage. Read instructions provided with the product prior to use. Empty containers may contain residual material; therefore, empty containers must be handled with care. PROTECTIVE PRACTICES DURING MAINTENANCE OF CONTAMINATED EQUIPMENT: Follow practices indicated in Section 6 (Accidental Release Measures). Make certain that application equipment is locked and tagged-out safely, as applicable. Collect all rinsates and dispose of according to applicable Federal, State, or local procedures. SECTION 8
EXPOSURE CONTROLS, PERSONAL PROTECTION
Monohydrate (exposure limit is for Lithium Oxide, a compound with similar hazard properties) NE = Not Established See Section 16 for Definition of other terms and acronyms used. The information presented is based only on Lithium Hydroxide. The Exposure Controls and Personal
LITHIUM HYDROXIDE MONOHYDRATE CFM 048-GHS
Page 3 of 6
SECTION 8
EXPOSURE CONTROLS, PERSONAL PROTECTION
Protection required will be dependent on the conditions present in the workplace, including the presence of
other chemicals. PPE should be based on a Hazard Assessment as required in 29CFR1910.132.

VENTILATION AND ENGINEERING CONTROLS: Use with adequate ventilation, to ensure exposures are below the occupational exposure limits provided above. Mechanical exhaust may be needed. RESPIRATORY PROTECTION: If ventilation is inadequate, an approved dust/mist respirator may be required. For higher exposures or in potentially oxygen deficient atmospheres, a supplied air respirator may be required. Respirator selection and use should be based on contaminant type, form and concentration. Follow OSHA 1910.134, ANSI Z88.2, CSA Standard Z94.4-02 and good Industrial Hygiene practice. EYE PROTECTION: Splash goggles and face shield. If necessary, refer to U.S. OSHA 29 CFR 1910.133, and appropriate Canadian Standards. HAND PROTECTION: Wear neoprene gloves for routine industrial use. If necessary, refer to U.S. OSHA 29 CFR 1910.138 and appropriate Standards of Canada. BODY PROTECTION: Use body protection appropriate for task (e.g., Apron or Protective suit). If a hazard of injury to the feet exists due to falling objects, rolling objects, where objects may pierce the soles of the feet or where employee’s feet may be exposed to electrical hazards, wear foot protection, as described in U.S. OSHA 29 CFR 1910.136. NOTE: Additional protection may be required for specific work situations in which Lithium Hydroxide is used. The potential exposure hazards for each work situation must be evaluated, per 29 CFR 1910.132 (Federal OSHA Personal Protective Equipment Standard/General requirements), to determine the appropriate personal protective equipment for the operation. Where there is any possibility that an employee's eyes may be exposed to Lithium Hydroxide, the employer should provide an eye wash fountain within the immediate work area for emergency use. SECTION 9
PHYSICAL AND CHEMICAL PROPERTIES
RELATIVE VAPOR DENSITY (air = 1): Not applicable. EVAPORATION RATE (nBuAc = 1): Not applicable. SPECIFIC GRAVITY (water = 1): SOLUBILITY IN WATER @ 10°C: 22.3 g/100 mL VAPOR PRESSURE, mm Hg @ 20°C: Not applicable. APPEARANCE AND COLOR: White, crystalline solid. AUTOIGNITION TEMPERATURE: Not applicable. FLAMMABLE LIMITS (in air by volume): Not applicable. BOILING POINT: Releases water @ 100°C (212°F); decomposes @ 924°C (1695°F) COEFFICIENT OF OIL/WATER DISTRIBUTION (PARTITION COEFFICIENT): Not available. HOW TO DETECT THIS SUBSTANCE (warning properties): Solid Lithium Hydroxide Monohydrate does not have any unique warning properties. Aqueous solutions of Lithium Hydroxide Monohydrate will turn litmus paper blue. SECTION 10
STABILITY AND REACTIVITY
STABILITY: Stable. Lithium Hydroxide Monohydrate may react with carbon dioxide in air to form lithium carbonate. DECOMPOSITION PRODUCTS: Thermal decomposition of the components of Lithium Hydroxide Monohydrate include lithium compounds and caustic vapors. MATERIALS WITH WHICH SUBSTANCE IS INCOMPATIBLE: Lithium Hydroxide, Monohydrate is not compatible with strong acids. Lithium Hydroxide, Monohydrate is corrosive to aluminum, lead, and zinc. HAZARDOUS POLYMERIZATION: Will not occur. CONDITIONS TO AVOID: Mixing Lithium Hydroxide Monohydrate with incompatible chemicals. SECTION 11
TOXICOLOGICAL INFORMATION
SYMPTOMS OF OVEREXPOSURE BY ROUTE OF EXPOSURE: In terms of anticipated occupational overexposure situations for employees, the main health effect from overexposure would be irritation or burns of contaminated skin, eyes, and tissues of the respiratory system. INHALATION: Inhalation of airborne dusts of Lithium Hydroxide Monohydrate dusts may severely irritate or damage the tissues of the eyes, nose, and respiratory system. Symptoms of such overexposure can include coughing, sneezing, and a sore throat. Inhalation of relatively large quantities of Lithium Hydroxide Monohydrate may damage the tissues of the respiratory system, which can lead to the development of breathing difficulty, chemical pneumonitis, and pulmonary edema (a potentially life-threatening accumulation of fluid in the lungs). Severe inhalation overexposure may be fatal. CONTACT WITH SKIN or EYES: Depending on the duration and concentration of overexposure, Lithium Hydroxide Monohydrate can cause severe irritation and corrosive damage to the skin and eyes. Symptoms of skin contact can include redness, irritation, pain, and burns that are slow to heal. Permanent scarring may occur. Repeated skin overexposure may cause dermatitis (dry, red skin). Symptoms of eye contact can include redness, LITHIUM HYDROXIDE MONOHYDRATE CFM 048-GHS
Page 4 of 6
SECTION 11
TOXICOLOGICAL INFORMATION
irritation, pain, tearing, and blurred vision. Severe eye overexposure may cause permanent damage or blindness.
SKIN ABSORPTION: Skin absorption is not a significant route of exposure for Lithium Hydroxide Monohydrate.
INGESTION: Ingestion is not anticipated to be a significant route of occupational exposure. If Lithium Hydroxide,
Monohydrate is swallowed, it can irritate and burn the mouth, throat, and other tissues of the digestive system.
Symptoms can include vomiting, diarrhea, and collapse. Vomiting (which can occur after ingestion of Lithium
Hydroxide, Monohydrate) may lead to aspiration, causing lung damage. In humans, ingestion of 10 grams of
Lithium Hydroxide, Monohydrate may be fatal. Severe ingestion overexposures can be fatal.
CHRONIC: Repeated skin overexposure may cause dermatitis (dry, red skin). Lithium poisoning may result in
kidney and central nervous system effects.
TARGET ORGANS: ACUTE: Eyes, skin, mucous membranes. CHRONIC: Skin, Nervous System, Kidney.
TOXICITY DATA: There are no toxicity data for Lithium Hydroxide Monohydrate. The following toxicological data are for the Anhydrous form of Lithium Hydroxide. LC50 (Inhalation-Rat) 960 mg/m3/4 hours LD50 (Oral-Rat) 210 mg/kg: LD LD50 (Oral-Mouse) 363 mg/kg Eye Irritation: In animal tests, solutions of Lithium Hydroxide are similar to solutions of sodium hydroxide, which can cause severe corrosive eye CARCINOGENICITY STATUS: Lithium Hydroxide is not listed as a carcinogen or suspected carcinogen by IARC, NTP, OSHA or ACGIH. IRRITANCY OF PRODUCT: This solution will cause severe irritation and corrosive damage to the skin, eyes, and any other contaminated tissue. SENSITIZATION TO THE PRODUCT: Lithium Hydroxide Monohydrate is not known to be a skin or respiratory sensitizer. REPRODUCTIVE TOXICITY INFORMATION: Listed below is information concerning the effects of Lithium Hydroxide Monohydrate on the human reproductive system. Mutagenicity: Lithium Hydroxide Monohydrate is not reported to cause mutagenic effects in humans. Embryotoxicity: Lithium Hydroxide Monohydrate is not reported to produce embryotoxic effects in humans Teratogenicity: Lithium Hydroxide Monohydrate is not reported to cause teratogenic effects in humans. Reproductive Toxicity: Lithium Hydroxide Monohydrate is not reported to cause reproductive effects in humans. ACGIH BIOLOGICAL EXPOSURE INDICES (BEIs): Currently there are no ACGIH Biological Exposure Indices (BEIs) determined for Lithium Hydroxide Monohydrate. SECTION 12
ECOLOGICAL INFORMATION
ALL WORK PRACTICES MUST BE AIMED AT ELIMINATING ENVIRONMENTAL CONTAMINATION. ENVIRONMENTAL STABILITY: Lithium Hydroxide Monohydrate may react with carbon dioxide in air to form lithium carbonate. EFFECT OF MATERIAL ON PLANTS or ANIMALS: Due to its corrosivity, Lithium Hydroxide Monohydrate can be harmful or fatal to contaminated plants and animals. EFFECT OF CHEMICAL ON AQUATIC LIFE: Due to its corrosivity, Lithium Hydroxide Monohydrate can be harmful or fatal to aquatic plants and animals in contaminated bodies of water. ACUTE AQUATIC TOXICITY: No data available. DEGRADABILITY: No data available. LOG BIOCONCENTRATION FACTOR (BCF): No data available. LOG OCTANOL/WATER PARTITION COEFFICIENT: No data available. SECTION 13
DISPOSAL CONSIDERATIONS
PREPARING WASTES FOR DISPOSAL: Waste disposal must be in accordance with appropriate U.S. Federal, State, and local regulations or with regulations of Canada and its Provinces. Lithium Hydroxide Monohydrate, if unaltered by use, may be disposed of by treatment at a permitted facility or as advised by your local solid waste regulatory authority. EPA WASTE NUMBER: D002 (Characteristic/Corrosivity), applicable to wastes consisting only of Lithium Hydroxide Monohydrate. LITHIUM HYDROXIDE MONOHYDRATE CFM 048-GHS
Page 5 of 6
SECTION 14
TRANSPORT INFORMATION
THIS MATERIAL IS HAZARDOUS AS DEFINED BY 49 CFR 172.101 BY THE U.S. DEPARTMENT OF TRANSPORTATION. HAZARD CLASS NUMBER and DESCRIPTION: 8 (Corrosive) UN IDENTIFICATION NUMBER: NORTH AMERICAN EMERGENCY RESPONSE GUIDEBOOK NUMBER (2000): 154 MARINE POLLUTANT: Lithium Hydroxide, Monohydrate is not designated as a DOT Marine Pollutant (49 CFR TRANSPORT CANADA TRANSPORTATION OF DANGEROUS GOODS REGULATIONS: This material is considered as Dangerous Goods, per regulations of Transport Canada. The use of the above U.S. DOT information from the U.S. 49 CFR regulations is allowed for shipments that originate in the U.S. For shipments via ground vehicle or rail that originate in Canada, the following information is applicable. EXPLOSIVE LIMIT & LIMITED QUANTITY INDEX: 1 ERAP INDEX: PASSENGER CARRYING ROAD OR RAIL VEHICLE INDEX: 15 MARINE POLLUTANT: No component of this product is listed as a marine pollutant under TC regulations. INTERNATIONAL AIR TRANSPORT ASSOCIATION DANGEROUS GOODS REGULATIONS: Use the following information for international shipments via air transport. PACKING INSTRUCTIONS: Passenger Aircraft: 814; Cargo Aircraft: 816 ERG CODE NUMBER: EMERGENCY RESPONSE CONTACT FOR AN INCIDENT DURING TRANSPORTATION: CHEMTREC 1-800-424-9300 or 1-703-527-3887 SECTION 15
REGULATORY INFORMATION
ADDITIONAL U.S. REGULATIONS:
U.S. SARA REPORTING REQUIREMENTS: Lithium Hydroxide Monohydrate is not subject to the reporting requirements of the Comprehensive Environmental Response, Compensation, and Liability Act and Sections 302, 304 and 313 of Title III of the Superfund Amendments and Reauthorization Act. CERCLA SECTION 103 (40 CFR 302.4) Listed CERCLA HAZARDOUS SUBSTANCE: No SARA SECTION 302 (40 CFR 355.30) EXTREMELY HAZARDOUS SUBSTANCE: No SARA SECTION 304 (40 CFR 355.40) RQ – CERCLA OR SARA 302: No SARA SECTION 313 (40 CFR 372.65) Toxic Chemical Release Inventory (TRI Form R): No U.S. SARA THRESHOLD PLANNING QUANTITY: There are no specific Threshold Planning Quantities for this product. The default Federal MSDS submission and inventory requirement filing threshold of 10,000 lb (4,540 kg) may apply, per 40 CFR 370.20. U.S. CERCLA REPORTABLE QUANTITY (RQ): Not applicable. U.S. TSCA INVENTORY STATUS: Lithium Hydroxide Monohydrate is not listed on the TSCA Inventory; however, as a hydrate of a listed material (lithium hydroxide), this material is exempted from listing. U.S. TSCA 12(b) EXPORT NOTIFICATION: TSCA 12(b) Notification is not required, per 40 CFR 707, for Lithium Hydroxide Monohydrate. OTHER U.S. FEDERAL REGULATIONS: Not applicable. LITHIUM HYDROXIDE MONOHYDRATE CFM 048-GHS
Page 6 of 6
SECTION 15
REGULATORY INFORMATION
U.S. STATE REGULATORY INFORMATION: Lithium Hydroxide Monohydrate is covered under specific State regulations, as denoted below: Massachusetts - Substance List: No. New Jersey - Right to Know Hazardous Substance List: : Lithium Michigan - Critical Materials Register: Lithium Compounds. Pennsylvania - Hazardous Substance List: No. CALIFORNIA SAFE DRINKING WATER AND TOXIC ENFORCEMENT ACT (PROPOSITION 65): Lithium Hydroxide Monohydrate is not on the California Proposition 65 lists. ADDITIONAL CANADIAN REGULATIONS:
CANADIAN DSL/NDSL INVENTORY STATUS: Lithium Hydroxide Monohydrate is on the DSL Inventory. CANADIAN WHMIS CLASSIFICATION AND SYMBOLS: Class E Corrosive
SECTION 16
OTHER INFORMATION
HAZARDOUS MATERIAL IDENTIFICATION SYSTEM RATING: Health Hazard = 3; Fire Hazard = 0; Physical Hazard = 0 NFPA RATING: Health Hazard = 3; Fire Hazard = 0; Instability Hazard = 0 4 = Severe Hazard 3 = Serious Hazard 2 = Moderate Hazard 1 = Slight Hazard 0 = Minimal Hazard REVISIONS MADE ON 2/23/06: All Sections – Conversion to GHS format The information in this Material Safety Data Sheet is based on data that Chemetall Foote Corporation believes to be reliable as of the MSDSs
date of revision. Chemetall Foote Corporation makes no warranty or representation of any kind that the MSDS does not contain errors. The
data in this MSDS relates only to the specific material designated herein and does not relate to use in combination with any other material or in
any process. It is intended for use by persons having technical skill and at their own discretion and risk. Since conditions of use are outside
the control of Chemetall Foote Corporation, there are no warranties, expressed or implied, and Chemetall Foote Corporation assumes no
liability in connection with the use of this information. Nothing herein is to be taken as a license to operate under or a recommendation to
infringe on any patents. Any use of these data and information must be determined by the user to be in accordance with Federal, State and
local laws and regulations.
DEFINITIONS OF EXPOSURE LIMIT TERMS AND ABBREVIATIONS
ACGIH
- American Conference of Governmental Industrial Hygienists, a professional association that establishes exposure limits. TLV -
Threshold Limit Value - an airborne concentration of a substance that represents conditions under which it is generally believed that nearly all
workers may be repeatedly exposed without adverse effect. The duration must be considered, including the 8-hour Time Weighted Average
(TWA)
, the 15-minute Short Term Exposure Limit, and the instantaneous Ceiling Level (C). Skin absorption effects must also be considered.
OSHA - U.S. Occupational Safety and Health Administration. PEL - Permissible Exposure Limit - This exposure value means exactly the same as
a TLV, except that it is enforceable by OSHA. The OSHA Permissible Exposure Limits are based on the 1989 PELs and the June, 1993 Air
Contaminants Rule (Federal Register: 58: 35338-35351 and 58: 40191). Both the current PELs and the vacated PELs are indicated. The phrase,
“Vacated 1989 PEL,” is placed next to the PEL which was vacated by Court Order.
IDLH - Immediately Dangerous to Life and Health - This level represents a concentration from which one can escape within 30-minutes without
suffering escape-preventing or permanent injury. The DFG MAK is the Republic of Germany’s Maximum Exposure Level, similar to the U.S.
PEL. NIOSH is the National Institute of Occupational Safety and Health, which is the research arm of the U.S. Occupational Safety and Health
Administration (OSHA). NIOSH issues exposure guidelines called Recommended Exposure Levels (RELs). When no exposure guidelines are
established, an entry of NE is made for reference.

Source: http://www.junhan.co.kr/data/lithium_Hydroxide_Mono_Hydrate.pdf

guildcare.com.au

Support Programs Frequently Asked Questions The purpose of this document is to provide information with regard to enrolling your patients into the Pfizer Patient Support Programs. Questions specifically regarding the GuildCare programs should be directed to: Web: www.guildcare.com.au Pfizer Patient Support Programs Frequently Asked Questions Question: Why does Pfizer offer Pa

have2020.com

2013 Patient Medical History Date of Birth: _____________________ Emergency Contact/Phone:________________________ Name: ___________________________ Pharmacy:____________________________________ Family Physician: _________________________ Referring Doctor: _______________________________ Do you wear? Glasses Contact Lenses (What type?) _______________________ □ No Glasses or Con

Copyright © 2010-2014 Pharmacy Pills Pdf